RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medican Enterprises Stock

Medican Enterprises P/E 2024

Medican Enterprises P/E

-1.14

Ticker

MDCN

ISIN

US58464T2024

As of Dec 4, 2024, Medican Enterprises's P/E ratio was -1.14, a 54.05% change from the -0.74 P/E ratio recorded in the previous year.

The Medican Enterprises P/E history

Medican Enterprises Aktienanalyse

What does Medican Enterprises do?

Medican Enterprises Inc is an innovative company specializing in the development and marketing of high-quality cannabis products. Founded by an experienced team of executives and scientists dedicated to researching and developing innovative products and technologies. The history of Medican Enterprises Inc dates back to 2012 when the company began as a research and development company in the medical cannabis industry. Since then, the company has become one of the most dynamic and leading companies in this field. The business model of Medican Enterprises Inc is based on the development and marketing of innovative products and technologies in the cannabis market. The company works closely with state regulatory authorities as well as science and research to develop and bring new product ideas to market. Medican Enterprises Inc utilizes its comprehensive expertise and experience in cannabis research to develop high-quality products that meet consumer needs. The business areas of Medican Enterprises Inc include various sectors such as the manufacturing of cannabis products, research and development, production of edible cannabis products, and the implementation of technologies to enhance the cannabis industry. The company produces and distributes a wide range of cannabis products, including medical products, CBD oils, concentrates, and vaporizers. Medican Enterprises Inc also offers a variety of edible products such as gummies, chocolates, cookies, and beverages. Another important area of Medican Enterprises is research and development in the cannabis industry. The company has extensive experience in developing new products and technologies that meet the market's demand for quality and effectiveness. This also includes innovative approaches in application and dosage to achieve maximum impact. Medican Enterprises Inc also has the technology and production capabilities to deliver perfect solutions for the production of high-quality cannabis products. The company works closely with many different manufacturers and suppliers to ensure continuous improvement and innovation in the industry. Overall, Medican Enterprises Inc has a wide portfolio of innovative and constantly evolving products in the medical cannabis industry. The company is committed to offering high-quality products and services while addressing the most common challenges in the cannabis industry, such as quality assurance and control in the production of cannabis products. As a pioneer and one of the leading companies in the industry, Medican Enterprises Inc is committed to advancing the cannabis industry and providing consumers with the best possible products and services. Clear leadership and years of experience, along with ongoing investments in research and development, drive Medican Enterprises Inc to new heights and lead to a high level of customer satisfaction and quality in the cannabis industry. Medican Enterprises ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Medican Enterprises's P/E Ratio

The Price to Earnings (P/E) Ratio of Medican Enterprises is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Medican Enterprises's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Medican Enterprises is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Medican Enterprises’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Medican Enterprises stock

What is the price-to-earnings ratio of Medican Enterprises?

The price-earnings ratio of Medican Enterprises is currently -1.14.

How has the price-earnings ratio of Medican Enterprises changed compared to last year?

The price-to-earnings ratio of Medican Enterprises has increased by 54.05% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Medican Enterprises high compared to other companies?

Yes, the price-to-earnings ratio of Medican Enterprises is high compared to other companies.

How does an increase in the price-earnings ratio of Medican Enterprises affect the company?

An increase in the price-earnings ratio of Medican Enterprises would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Medican Enterprises affect the company?

A decrease in the price-earnings ratio of Medican Enterprises would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Medican Enterprises?

Some factors that influence the price-earnings ratio of Medican Enterprises are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Medican Enterprises pay?

Over the past 12 months, Medican Enterprises paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medican Enterprises is expected to pay a dividend of 0 USD.

What is the dividend yield of Medican Enterprises?

The current dividend yield of Medican Enterprises is .

When does Medican Enterprises pay dividends?

Medican Enterprises pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medican Enterprises?

Medican Enterprises paid dividends every year for the past 0 years.

What is the dividend of Medican Enterprises?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medican Enterprises located?

Medican Enterprises is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medican Enterprises kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medican Enterprises from 12/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.

When did Medican Enterprises pay the last dividend?

The last dividend was paid out on 12/4/2024.

What was the dividend of Medican Enterprises in the year 2023?

In the year 2023, Medican Enterprises distributed 0 USD as dividends.

In which currency does Medican Enterprises pay out the dividend?

The dividends of Medican Enterprises are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medican Enterprises

Our stock analysis for Medican Enterprises Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medican Enterprises Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.